These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26167957)

  • 1. Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--a clinical overview.
    Shah M; Younossi ZM; Opsha Y
    Am J Manag Care; 2015 Mar; 21(5 Suppl):S76-85. PubMed ID: 26167957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--diagnosis and management.
    Shah M; Younossi ZM
    Am J Manag Care; 2015 Mar; 21(5 Suppl):S86-96. PubMed ID: 26167958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and treating hepatitis C virus infection.
    Schiff ER
    Am J Manag Care; 2011 Mar; 17 Suppl 4():S108-15. PubMed ID: 21767067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
    Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
    JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
    Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
    N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C therapy: Looking toward interferon-sparing regimens.
    Au TH; Destache CJ; Vivekanandan R
    J Am Pharm Assoc (2003); 2015; 55(2):e72-84; quiz e85-6. PubMed ID: 25658389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; Martin MT; Chan J; Dilworth TJ; El-Lababidi R; Love BL; Mohammad RA; Nguyen A; Spooner LM; Wortman SB
    Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
    AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.
    Van den Eynde E; Crespo M; Esteban JI; Jardi R; Ribera E; Carbonell J; Rodríguez-Frias F; Falco V; Curran A; Imaz A; Villar del Saz S; Ocaña I; Esteban R; Pahissa A
    Clin Infect Dis; 2009 Apr; 48(8):1152-9. PubMed ID: 19275492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
    Sterling RK; Sulkowski MS
    Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
    Mandorfer M; Reiberger T; Payer BA; Ferlitsch A; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Trauner M; Peck-Radosavljevic M;
    AIDS; 2013 Jan; 27(2):227-32. PubMed ID: 23238552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
    Michielsen P; Ho E; Francque S
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic approaches for hepatitis C.
    Au JS; Pockros PJ
    Clin Pharmacol Ther; 2014 Jan; 95(1):78-88. PubMed ID: 24126682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.
    Armignacco O; Andreoni M; Sagnelli E; Puoti M; Bruno R; Gaeta GB; Perno CF; Santantonio TA; Bonfanti P; Bonora S; Borderi M; Castagna A; d'Arminio Monforte A; De Luca A; Grossi P; Guaraldi G; Maggiolo F; Mussini C; Sagnelli C; Tavio M; Torti C; Uberti-Foppa C; Andreoni M; Angarano G; Antinori A; Armignacco O; Carosi G; Chirianni A; Di Perri G; Galli M; Lazzarin A; Rizzardini G; Sagnelli E; Taliani G
    New Microbiol; 2014 Oct; 37(4):423-38. PubMed ID: 25387281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--the new and evolving standards of care.
    Owens GM
    Am J Manag Care; 2015 Mar; 21(5 Suppl):S97-105. PubMed ID: 26167959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapies for hepatitis C virus.
    Birerdinc A; Younossi ZM
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):535-44. PubMed ID: 20629602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis C in children.
    González-Peralta RP
    Pediatr Transplant; 2004 Dec; 8(6):639-43. PubMed ID: 15598340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatitis C virus infection in childhood.
    Galoppo M; Galoppo C
    Ann Hepatol; 2010; 9 Suppl():98-102. PubMed ID: 20714004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.